ConductScience.org, home

Gene · 900

NIH grants1,201

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCCNG1 papersNewest fiscal year
R01DK058110Dose-Dependent Effects of Hormone on the Activity of Estrogen Receptor Enhancers and Target Genes22025
R01DK072381Kidney Injury Molecule-1 in Epithelial Repair22025
R01DK103794Systematic Genetic Dissection of Human Erythropoiesis22025
R01DK121101The role of cyclin G1 and CDK5 in chronic kidney disease.22025
R01HL146500Next generation functional genomics of hematology traits22025
R35GM133552Coordination of chaperone interactions that dictate protein folding and trafficking22025
T32ES007015Molecular & Environmental Toxicology Predoctoral Training Program22025
U01AI144616DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity22025
U54GM104940Louisiana Clinical and Translational Science Center22025
U54MD012392RCMI Center for Health Disparities Research22025
ZIABC010441Biomolecular Recognition and Binding Mechanisms22025
IK6BX005646BLR&D Research Career Scientist Award Application (Renewal)12025
K12CA184746MSK Paul Calabresi Career Development Award for Clinical Oncology12025
KL2TR001882Institutional Career Development Core12025
P01CA013106Targeting Transcription and Splicing in Cancer12025
P01CA018029Adult Leukemia Research Center12025
P01CA019014Viral Oncogenesis, Latency, and Replication12025
P01CA163222Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment12025
P01CA163227Androgen Receptor Action in Castration Resistant Prostate Cancer12025
P20GM103429Partnerships for Biomedical Research in Arkansas12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/900/grants?page=2